Cautious on Yahoo! ...
Health Care: Drugs
Halozyme Therapeutics Inc. (HALO: NASDAQ)
$7.45 0.28 | 3.91%
05/23/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| HALO | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 30.64 | -14.13 | 14.65 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -24.50 | 2.10 | 0.45 |
| Net Income | -0.08 | 0.00 | |
| EPS | -0.28 | 0.00 |
Earnings for HALO:
| EBITDA | -52.00 |
| REVENUE | 42.33M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.14 | $-0.14 | $-0.57 | $-0.45 |
| Number of Analysts | 5 | 5 | 6 | 5 |
| High Estimate | $-0.10 | $-0.08 | $-0.44 | $-0.34 |
| Low Estimate | $-0.19 | $-0.24 | $-0.75 | $-0.67 |
| Prior Year | $-0.13 | $-0.18 | $-0.48 | $-0.57 |
| Growth Rate (Year over Year) | -9.23% | 21.11% | -19.79% | 21.74% |
Portfolios with HALO
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- UserWatch
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks With Big Insider Buy...
- Contributor3 Stocks to Buy for Less Th...
- UserGFNN Stockdiagnostics 6
- ContributorStocks With Big Insider Buy...
- ContributorStocks At New 52-Week Highs...
Latest HALO Headlines from TheStreet
- Ahead Of The Trend: 7 Rallying Stocks With Institutional Selling And Short Increases 05.23.13 | 02:05 pm
- Quick Take: The Next Big Thing in Biotech 05.17.13 | 10:05 am
- Biotech's Next Big Thing ASCO II
05.16.13 | 02:05 pm - 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- Short Interest Increases 11.2% For HALO 05.10.13 | 03:05 pm
- 4 Under-$10 Stocks Making Big Moves 04.23.13 | 03:04 pm
- HALO Makes Bullish Cross Above Critical Moving Average 04.23.13 | 11:04 am
- 7 Stocks Under $10 Moving Higher 11.15.12 | 03:11 pm
- 5 Stocks With Big Insider Buying 08.29.12 | 11:08 am
- Halozyme Therapeutics Management Discusses Q2 2012 Results - Earnings Call Transcript 08.06.12 | 07:08 pm
Press Releases for HALO
- Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer - PR Newswire 05.23.13 | 08:05 am
- Halozyme To Present New Data On PEGPH20 In Pancreatic Cancer At American Society Of Clinical Oncology Annual Meeting - PR Newswire 05.15.13 | 06:05 pm
- Halozyme Therapeutics To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference - PR Newswire 05.07.13 | 04:05 pm
- Halozyme To Host First Quarter 2013 Financial Results Conference Call - PR Newswire 05.01.13 | 04:05 pm
- Halozyme Initiates Randomized Phase 2 Trial Of PEGPH20 In Pancreatic Cancer - PR Newswire 04.23.13 | 08:04 am
- Halozyme Therapeutics Names Matt Posard To Board Of Directors - PR Newswire 03.28.13 | 04:03 pm
- Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union - PR Newswire 03.22.13 | 08:03 am
- Halozyme Therapeutics To Present At The Barclays 2013 Global Healthcare Conference - PR Newswire 03.05.13 | 04:03 pm
- Halozyme To Host Fourth Quarter And 2012 Year-End Financial Results Conference Call - PR Newswire 02.19.13 | 04:02 pm
- Halozyme Therapeutics Issues Financial Guidance For 2013 - PR Newswire 01.07.13 | 07:01 am
Partner Headlines for HALO
- Halozyme Therapeutics Earnings: Here’s Why Investors are Ambivalent Now - Wall St. Cheat Sheet 05.08.13 | 07:05 am
- Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR) - Benzinga 03.23.13 | 11:03 am
- Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus - Benzinga 03.22.13 | 04:03 pm
- Pertaining to Relief for ViroPharma - Analyst Blog - NASDAQ 09.25.12 | 07:09 pm
- ViroPharma Misses Zacks Estimates - Analyst Blog - Zacks 08.10.12 | 09:08 am
- VPHM Manufacturing Process Approved - Analyst Blog - Zacks 08.07.12 | 07:08 pm
- Bad News for ViroPharma - Analyst Blog - Zacks 08.03.12 | 06:08 pm
- After Hours Most Active for Aug 1, 2012 : SAN, GMCR, NOK, FSLR, BBVA, SBUX, BAC, JNJ, LEN, HALO, QQQ, SPLS - NASDAQ 08.01.12 | 08:08 pm
- Rituxan And Its Biosimilar Competitors - Seeking Alpha 07.30.12 | 09:07 am
- Healthcare Biz Recap: GlaxoSmithKline BUYS Drugs, Sanofi Gains Traction - Wall St. Cheat Sheet 06.12.12 | 06:06 am
